Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early High-dose Erythropoietin Therapy and Hypothermia After Out-of-hospital Cardiac Arrest: A Matched Control Study

NCT00719498 is registered in ClinicalTrials.gov with Janssen Cilag S.A.S. as lead sponsor.

NCT NCT00719498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00719498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early High-dose Erythropoietin Therapy and Hypothermia After Out-of-hospital Cardiac Arrest: A Matched Control Study
Lead sponsor
Janssen Cilag S.A.S.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2003
Completion date
July 31, 2004
Enrollment
20 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, cardiopulmonary, resuscitation